How to Control Impurities during API drug manufacturing
Posted: February 19, 2018
Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about Controlling Impurities during API drug manufacturing.
Related posts:
10 Steps to Control or Eliminate Genotoxic Impurities in API Manufacturing
Internal Auditing: A Sound Business Practice to Ensure Successful Project Outcomes in cGMP Manufact...
Everything You Wanted to Know About Polymer Synthesis But Were Afraid To Ask
What Should You Look for In a Consultant to Manage Your Prized API Project?
7 Questions to Ask to Get the Most From API Manufacturing